OPCH Quote, Financials, Valuation and Earnings

Amedisys has a net margin of 3.51% compared to Option Care Health's net margin of 10.26%. Option Care Health's return on equity of 15.22% beat Amedisys's return on equity of 7.55%.

Option Care Health has a consensus price target of $38.56, signalling upside risk potential of 26.89%. On the other hand Amedisys has an analysts' consensus of $97.38 which suggests that it could fall by -0.11%. Given that Option Care Health has higher upside potential than Amedisys, analysts believe Option Care Health is more attractive than Amedisys.

Option Care Health has a beta of 0.731, which suggesting that the stock is 26.892% less volatile than S&P 500. In comparison Amedisys has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.651%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than Amedisys quarterly revenues of $594.8M. Option Care Health's net income of $46.7M is lower than Amedisys's net income of $61M. Notably, Option Care Health's price-to-earnings ratio is 24.50x while Amedisys's PE ratio is 35.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.00x versus 1.36x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

Chemed has a net margin of 3.51% compared to Option Care Health's net margin of 11.09%. Option Care Health's return on equity of 15.22% beat Chemed's return on equity of 26.04%.

Option Care Health has a consensus price target of $38.56, signalling upside risk potential of 26.89%. On the other hand Chemed has an analysts' consensus of $646.67 which suggests that it could grow by 41.41%. Given that Chemed has higher upside potential than Option Care Health, analysts believe Chemed is more attractive than Option Care Health.

Option Care Health has a beta of 0.731, which suggesting that the stock is 26.892% less volatile than S&P 500. In comparison Chemed has a beta of 0.496, suggesting its less volatile than the S&P 500 by 50.426%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Chemed offers a yield of 0.44% to investors and pays a quarterly dividend of $0.50 per share. Option Care Health pays -- of its earnings as a dividend. Chemed pays out 8.97% of its earnings as a dividend. Chemed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Option Care Health quarterly revenues are $1.3B, which are larger than Chemed quarterly revenues of $646.9M. Option Care Health's net income of $46.7M is lower than Chemed's net income of $71.8M. Notably, Option Care Health's price-to-earnings ratio is 24.50x while Chemed's PE ratio is 22.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.00x versus 2.76x for Chemed. Usually stocks with elevated PS ratios are considered overvalued.

Humana has a net margin of 3.51% compared to Option Care Health's net margin of 3.87%. Option Care Health's return on equity of 15.22% beat Humana's return on equity of 10.08%.

Option Care Health has a consensus price target of $38.56, signalling upside risk potential of 26.89%. On the other hand Humana has an analysts' consensus of $291.58 which suggests that it could grow by 28.7%. Given that Humana has higher upside potential than Option Care Health, analysts believe Humana is more attractive than Option Care Health.

Option Care Health has a beta of 0.731, which suggesting that the stock is 26.892% less volatile than S&P 500. In comparison Humana has a beta of 0.441, suggesting its less volatile than the S&P 500 by 55.925%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana offers a yield of 1.56% to investors and pays a quarterly dividend of $0.89 per share. Option Care Health pays -- of its earnings as a dividend. Humana pays out 35.71% of its earnings as a dividend. Humana's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Option Care Health quarterly revenues are $1.3B, which are smaller than Humana quarterly revenues of $32.1B. Option Care Health's net income of $46.7M is lower than Humana's net income of $1.2B. Notably, Option Care Health's price-to-earnings ratio is 24.50x while Humana's PE ratio is 16.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.00x versus 0.23x for Humana. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of 3.51% compared to Option Care Health's net margin of -10.03%. Option Care Health's return on equity of 15.22% beat OptimizeRx's return on equity of -13.03%.

Option Care Health has a consensus price target of $38.56, signalling upside risk potential of 26.89%. On the other hand OptimizeRx has an analysts' consensus of $15.67 which suggests that it could grow by 10.56%. Given that Option Care Health has higher upside potential than OptimizeRx, analysts believe Option Care Health is more attractive than OptimizeRx.

Option Care Health has a beta of 0.731, which suggesting that the stock is 26.892% less volatile than S&P 500. In comparison OptimizeRx has a beta of 1.343, suggesting its more volatile than the S&P 500 by 34.25%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than OptimizeRx quarterly revenues of $21.9M. Option Care Health's net income of $46.7M is higher than OptimizeRx's net income of -$2.2M. Notably, Option Care Health's price-to-earnings ratio is 24.50x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.00x versus 2.76x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.